Advice You - Business

There have been countless books written, audio and video programs recorded and seminars created for the sole purpose of teaching salespeople how

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

to close sales. While there are a great many ideas to be gleaned from each of these sources, the art of closing sales does not need to be that co

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

plicated!

Remember that a customer is not yet your customer until they actually buy something from you. If you then desire to keep them as a cus

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

tomer, you will also need to be certain that they are happy and satisfied with you, your product or service as well as your customer service depa

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

tment. Until the sale is achieved, they remain a prospective customer or a prospect.

Closing should be the natural result of an effective and co

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

mprehensive sales plan involving proper qualification of your prospect, sufficient pre-approach research, proper questioning to understand the cu

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

tomer's needs, a successful presentation of the features, advantages and benefits (FAB's) of your product or service, effectively handling of any

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

objections and then asking for the order. The closing segment is simply an ongoing part of the process, one that should naturally result from su

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

cessful implementation of the earlier steps.

Trial closes, smaller closes built into the presentation leading to the final close, are actually a

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

n integral component of the presentation process itself. These trial closes are simply points in the selling process where your prospect agrees t

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

at moving forward in the sales process is a good and worthwhile decision. Each is an affirmation that you, the salesperson, are on the right trac

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

.

Selling is actually the process of helping your prospect to buy. The job of the salesperson is to help clarify their particular need and prope

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

rly match the product or service to meet or exceed that need. Since many people do not like to make decisions, our job is simply to help them dec

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

de that by purchasing from us, their need is met in a most satisfying manner. They must clearly see that the value they get from your product or

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

service exceeds the money that they will spend in acquiring it.

"Closing the sale" simply means "asking for the order." If you don't ask, the an

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

wer is always "no." Closing of the sale is a natural step in the selling process. It should not involve any apprehension or fear on your part. It

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

is the right thing to do. It amazes me how many salespeople will do everything else properly and then fail to ask for the order! There is nothin

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

to fear. In most instances, the prospect is waiting for you to ask for their business. Do not let them down. Ask for the order.

Again, "closing

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

the sale" simply means asking for the order. Assuming that you have performed the preceding steps properly, "asking for the order" is a natural

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

egue and should flow without hesitation. Don't be embarrassed or fearful to close. Your customer expects it. Your sales will not grow without it

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/37724/adviceyou-Sales-101-Learn-How-to-Close-the-Sale.html">Sales 101: Learn How to Close the Sale</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/37724/adviceyou-Sales-101-Learn-How-to-Close-the-Sale.html]Sales 101: Learn How to Close the Sale[/url]

Diversity encases many more attributes than gender and skin tone, and a celebration and/or honoring of those differences. Many attributes are used to sort people out, to place them in categories, often with ideas of better or lesser.

In today’s climate of business, CEOs and executives are cautiously optimistic about the economy and their company’s future growth. They realize that they still need to market to drive profitable growth and increase the company’s value, but the financial strings are being tightened. However, there is a clear growing trend for companies, regardless of size and industry, to outsource (or a term used not to long ago sub-contracting) an element of their business. Why does this trend continue to grow, and how do executives assess their needs? Outsourcing is not a passing fad, but clearly a paradigm shift that can change a business model for the better.

Tags

Links

Advice You - Sales 101: Learn How to Close the Sale

Related Articles: